Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2026-05-13 @ 7:18 AM
Study NCT ID:
NCT04898894
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-16
First Post:
2021-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor:
St. Jude Children's Research Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SELCLAX
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None